Transplante – Fígado
Estudo randomizado | Impacto de máquina portátil normotérmica de perfusão sobre os desfechos de transplante hepático.
4 Fev, 2022 | 15:09hComentários:
Normothermic Machine Perfusion Improves Outcomes in Liver Transplant Recipients – Physician’s Weekly
Machine Perfusion Cuts Early Graft Dysfunction in Liver Transplantation – MedPage Today (necessário cadastro gratuito)
Conteúdos relacionados:
RCT: Hypothermic machine perfusion in liver transplantation
Transplantation of Discarded Livers Following Viability Testing with Normothermic Machine Perfusion
Comentários no Twitter
Study found portable normothermic oxygenated machine perfusion of donor liver grafts resulted in improved outcomes of liver transplantation and in more livers being transplanted. https://t.co/PZzvFriJvB pic.twitter.com/2icSfxoLDF
— JAMA Surgery (@JAMASurgery) January 5, 2022
Study found portable normothermic oxygenated machine perfusion of donor liver grafts resulted in improved outcomes of liver transplantation and in more livers being transplanted. https://t.co/TKEsTf8Htu pic.twitter.com/tg2xDGDyOS
— JAMA Surgery (@JAMASurgery) January 5, 2022
Diretriz de consenso sobre tratamento hemostático, anticoagulação e terapia antiplaquetária no transplante hepático.
20 Jan, 2022 | 22:44hDiretriz clínica | Insuficiência hepática crônica agudizada.
12 Jan, 2022 | 12:58hAcute-on-Chronic Liver Failure Clinical Guidelines – American Journal of Gastroenterology
Conteúdo relacionado: Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU
Comentário no Twitter
📣NEW ACG Guidelines Acute-on-Chronic #Liver Failure by @JasmohanBajaj et al.
📕https://t.co/T3CqvOAMrj#Cirrhosis #GItwitter #LiverTwitter #MostReadinRed pic.twitter.com/LHwIkUtGZt
— AJG – The American Journal of Gastroenterology (@AmJGastro) January 10, 2022
Estudo randomizado | Maribavir para infecções por citomegalovírus refratárias com ou sem resistência pós-transplante.
7 Dez, 2021 | 11:29hRevisão | Tratamento do distúrbio de uso do álcool em pacientes com cirrose num contexto de transplante hepático.
3 Nov, 2021 | 11:02h
Comentário no Twitter
New content online: Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation https://t.co/sWd1Vs6N2c pic.twitter.com/XZo8ETzhEl
— Nature Reviews Gastroenterology & Hepatology (@NatRevGastroHep) November 2, 2021
Diretriz de consenso | Transplante hepático para metástases hepáticas e colorretais não ressecáveis.
17 Set, 2021 | 12:22hLiver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines – The Lancet Gastroenterology & Hepatology (necessário cadastro gratuito)
Comentário no Twitter
New online – Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelineshttps://t.co/oZL4X4h7VS@IHPBA @gbonneysurg @eahpba @_ilts_#livertwitter #APHPBA_2021 pic.twitter.com/g6rrVclV5h
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) September 8, 2021
FDA autoriza aplicação de dose adicional da vacina contra Covid-19 em indivíduos imunocomprometidos – As demais pessoas, já plenamente vacinadas, não precisam de dose adicional neste momento.
16 Ago, 2021 | 12:10hComentários:
CDC, FDA recommend COVID booster for immune-compromised – CIDRAP
FDA authorizes additional dose of Covid-19 vaccine for the immunocompromised – STAT
Covid booster: US approves third jab for the immunocompromised – BBC
CDC Panel Recommends 3rd Vaccine Dose For Immunocompromised People – NPR
6 Things To Know If You’re Immunocompromised And Considering A 3rd Shot – NPR
CDC recommends third Covid-19 vaccine dose for certain immunocompromised people – CNN
Comentário no Twitter
The Infectious Diseases Society of America (IDSA) supports the @FDA and @CDCgov's decision to authorize a supplemental vaccine dose for immunocompromised patients.
Read our statement: https://t.co/odzzSgIxnY pic.twitter.com/4PZfUwpjhM
— IDSA (@IDSAInfo) August 13, 2021
Estudo randomizado | Terceira dose da vacina de mRNA da Moderna aumenta a imunidade em receptores de transplantes.
12 Ago, 2021 | 12:28hEditorial: Third Time’s a Charm — Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients
Conteúdos relacionados:
[Preprint] 3rd AstraZeneca shot gives strong immunity.
Comentários no Twitter
..1st randomized trial results of 3rd doses of Moderna vax for 120 people with organ transplants: month 4, their minimum anti-RBD antibody levels were 55% for 3rd dose vs 18% (still increasing a little in the placebo group). No cases of acute rejection https://t.co/BcfeyUEhx5 #IC
— Hilda Bastian, PhD (@hildabast) August 11, 2021
The authors conclude that a third-dose booster of mRNA-1273 vaccine should be considered for transplant recipients. https://t.co/Q3gakSaNjd pic.twitter.com/CMN8f7cq29
— NEJM (@NEJM) August 11, 2021
3 doses de vacina de mRNA contra Covid-19 em receptores de transplante de órgão sólido pode melhorar a imunogenicidade da vacina.
24 Jun, 2021 | 11:05hSérie de casos | Segurança e imunogenicidade de uma terceira dose de vacina contra SARS-CoV-2 em transplantados receptores de órgãos sólidos.
15 Jun, 2021 | 11:24hComentários: For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection – Hopkins Medicine E Extra COVID Vaccine May Help Protect Transplant Patients – Associated Press
Comentário no Twitter
Our report about 3rd vaccine doses in transplant patients is published! "It is encouraging that antibody titers increased after the 3rd dose in 1/3 of patients who had negative antibody titers and in all patients who had low-positive antibody titers"https://t.co/6XElwyIdAa
— Dorry Segev (@Dorry_Segev) June 14, 2021